Status:

RECRUITING

Evaluation of the Impact of the EDIT-B® Blood Test on the Health Status of Patients Presenting a Major Depressive Episode. Clinical Utility and Medico-Economic Aspects

Lead Sponsor:

Alcediag

Collaborating Sponsors:

BPIfrance

Synlab Holding Deutschland GmbH

Conditions:

Bipolar Disorder

Major Depressive Disorder

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Depression is one of the most common mental disorders, affecting nearly 10% of men and 20% of women worldwide. It is associated with a significant increase in mortality, mainly due to suicidal behavio...

Eligibility Criteria

Inclusion

  • Patients with a MDE, moderate to severe (DSM V criteria and MADRS score ≥19)
  • Age between 18 and 65 years, gender indifferent
  • Benefitting from health insurance coverage
  • Having signed an informed consent and agreed to follow the study protocol to completion
  • Patients for whom there is doubt regarding a bipolar disorder diagnosis, and/or presenting one or more of the following criteria:
  • More than 3 episodes of MDE in personal medical history
  • Psychotic symptoms
  • Family history of bipolar disorder
  • Onset of the first MDE before the age of 25
  • Atypical symptoms or mixed features during depressive episodes
  • Addiction
  • Personal history of suicide attempts
  • Resistance to antidepressants
  • Postpartum depression within 6 months of birth

Exclusion

  • Depression in the context of schizophrenia or autism spectrum disorder
  • Patient with a well-established diagnosis of bipolar disorder
  • Patients who is already receiving a mood stabilizer
  • Severe somatic diseases that may interfere with the follow-up or associated with treatments at risk of secondary manic decompensation
  • Neurodegenerative diseases
  • Pregnant women

Key Trial Info

Start Date :

February 3 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2027

Estimated Enrollment :

450 Patients enrolled

Trial Details

Trial ID

NCT06507787

Start Date

February 3 2025

End Date

May 1 2027

Last Update

February 18 2025

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

CH Erstein

Erstein, France

2

AP-HP Corentin Celton

Issy-les-Moulineaux, France

3

Etablissement Public de Santé Mentale (EPSM) 74

La Roche-sur-Foron, France

4

Clinique Villa des Roses

Lyon, France

Evaluation of the Impact of the EDIT-B® Blood Test on the Health Status of Patients Presenting a Major Depressive Episode. Clinical Utility and Medico-Economic Aspects | DecenTrialz